In rodents, at PTSD the level of hippocampal IL-1β was elevated, and the use of immunomodulatory preparations reduced it along with a decrease anxious behavior that is related to this disorder (Waheed et al., 2018). This evidence concerns the gene IL1B and post-traumatic stress disorder.